Clinical trial

A Study of AQUAVAN® Injection for Sedation in Elderly Patients Undergoing…

NCT00209586 · Eisai Inc., Industry · Terminated

Key facts

NCT number NCT00209586
Title A Study of AQUAVAN® Injection for Sedation in Elderly Patients Undergoing Flexible Bronchoscopy
Official title A Phase III, Randomized, Open-label Study to Assess the Safety and Efficacy of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Flexible Bronchoscopy Procedures
Lead sponsor Eisai Inc., Industry
Collaborators PPD Development, LP Industry Covance Quest Pharmaceutical Services
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Flexible Bronchoscopy
Intervention type Drug
Interventions fospropofol disodium
Enrollment 55
Start date Sep 1, 2004
Primary completion Mar 1, 2005
Completion Mar 1, 2005
First posted Sep 21, 2005
Last update posted Jun 15, 2023

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies